These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2999209)
21. Opiate receptors and anterior pituitary hormone secretion in man. Effect of naloxone infusion. Delitala G; Devilla L; Arata L Acta Endocrinol (Copenh); 1981 Jun; 97(2):150-6. PubMed ID: 6263025 [TBL] [Abstract][Full Text] [Related]
22. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors. Rivest S; Plotsky PM; Rivier C Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996 [TBL] [Abstract][Full Text] [Related]
23. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys. Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704 [TBL] [Abstract][Full Text] [Related]
24. The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women. Nappi C; Petraglia F; de Chiara BM; Genazzani AD; Montemagno R; Genazzani AR; Montemagno U Acta Obstet Gynecol Scand; 1991; 70(6):435-9. PubMed ID: 1763606 [TBL] [Abstract][Full Text] [Related]
25. [Effect of blockade of opiate receptors by naloxone on lutropin (LH), follitropin (FSH) and testosterone secretion in patients after kidney transplantation]. Grzeszczak W; Zukowska-Szczechowska E; Kokot F Pol Arch Med Wewn; 1992; 87(4-5):250-7. PubMed ID: 1326100 [TBL] [Abstract][Full Text] [Related]
26. Unexpected inhibitory action of N-methyl-D,L-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis. Reyes A; Luckhaus J; Ferin M Endocrinology; 1990 Aug; 127(2):724-9. PubMed ID: 2197080 [TBL] [Abstract][Full Text] [Related]
27. Estrogen changes as a critical factor in modulation of central opioid tonus: possible correlations with post-menopausal migraine. Genazzani AR; Petraglia F; Volpe A; Facchinetti F Cephalalgia; 1985 May; 5 Suppl 2():212-4. PubMed ID: 2990722 [TBL] [Abstract][Full Text] [Related]
28. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Petraglia F; Porro C; Facchinetti F; Cicoli C; Bertellini E; Volpe A; Barbieri GC; Genazzani AR Life Sci; 1986 Jun; 38(23):2103-10. PubMed ID: 3086650 [TBL] [Abstract][Full Text] [Related]
29. Failure of naloxone to stimulate luteinizing hormone secretion during pregnancy and steroid treatment of ovariectomized beef cows. Rund LA; Thompson FN; Byerley DJ; Kiser TE Biol Reprod; 1990 Apr; 42(4):619-24. PubMed ID: 2346772 [TBL] [Abstract][Full Text] [Related]
30. Gonadectomy influences the inhibitory effect of the endogenous opiate system on pulsatile gonadotropin secretion. Masotto C; Negro-Vilar A Endocrinology; 1988 Aug; 123(2):747-52. PubMed ID: 2840268 [TBL] [Abstract][Full Text] [Related]
31. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate. Gindoff PR; Ferin M Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919 [TBL] [Abstract][Full Text] [Related]
32. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women. Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330 [TBL] [Abstract][Full Text] [Related]
33. A decline in endogenous opioid influence during the steroid-induced hypersecretion of luteinizing hormone in the rat. Gabriel SM; Berglund LA; Simpkins JW Endocrinology; 1986 Feb; 118(2):558-61. PubMed ID: 3510853 [TBL] [Abstract][Full Text] [Related]
34. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia. Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944 [TBL] [Abstract][Full Text] [Related]
35. An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge. Sahu A; Crowley WR; Kalra SP Endocrinology; 1990 Feb; 126(2):876-83. PubMed ID: 2404749 [TBL] [Abstract][Full Text] [Related]
36. Episodic luteinizing-hormone release in the ovariectomized female guinea pig: rapid inhibition by estrogen. Condon TP; Dykshoorn-Bosch MA; Kelly MJ Biol Reprod; 1988 Feb; 38(1):121-6. PubMed ID: 3284595 [TBL] [Abstract][Full Text] [Related]
37. Effects of intracerebroventricular administration of opiate receptor antagonists on the suppressed pulsatile LH release during acute fasting in ovariectomized estradiol-treated rats. Cagampang FR; Maeda K Life Sci; 1991; 49(24):1823-8. PubMed ID: 1658522 [TBL] [Abstract][Full Text] [Related]
38. Modulation of endogenous opioid influence on luteinizing hormone secretion by progesterone and estrogen. Gabriel SM; Simpkins JW; Kalra SP Endocrinology; 1983 Nov; 113(5):1806-11. PubMed ID: 6313330 [TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges. Bauer-Dantoin AC; McDonald JK; Levine JE Endocrinology; 1992 Dec; 131(6):2946-52. PubMed ID: 1446632 [TBL] [Abstract][Full Text] [Related]
40. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women. Parra A; Barrón J; Marín VA; Coutiño B; Belmont J; Coria I Maturitas; 1997 May; 27(1):91-9. PubMed ID: 9158083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]